Article Information
vol. 8 no. 334 334ra53
- Received for publication August 24, 2015
- Accepted for publication March 16, 2016
- .
Author Information
- Justin M. Balko1,2,3,*,†,
- Luis J. Schwarz1,†,
- Na Luo1,
- Mónica V. Estrada3,4,
- Jennifer M. Giltnane3,4,‡,
- Daniel Dávila-González5,
- Kai Wang6,
- Violeta Sánchez1,
- Phillip T. Dean1,
- Susan E. Combs7,
- Donna Hicks2,
- Joseph A. Pinto8,
- Melissa D. Landis5,
- Franco D. Doimi9,
- Roman Yelensky6,§,
- Vincent A. Miller6,
- Phillip J. Stephens6,
- David L. Rimm7,
- Henry Gómez9,
- Jenny C. Chang5,
- Melinda E. Sanders3,4,
- Rebecca S. Cook2,3 and
- Carlos L. Arteaga1,2,3,*
- 1Department of Medicine, Vanderbilt University, Nashville, TN 37232, USA.
- 2Department of Cancer Biology, Vanderbilt University, Nashville, TN 37232, USA.
- 3Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN 37232, USA.
- 4Department of Pathology, Microbiology, and Immunology, Vanderbilt University, Nashville, TN 37232, USA.
- 5Houston Methodist Cancer Center, Houston, TX 77030, USA.
- 6Foundation Medicine, Cambridge, MA 02142, USA.
- 7Departments of Pathology and Medicine, Yale University, New Haven, CT 06520, USA.
- 8Oncosalud, Lima 41, Perú.
- 9Instituto Nacional de Enfermedades Neoplásicas (INEN), Lima 34, Perú.
- ↵*Corresponding author. E-mail: carlos.arteaga{at}vanderbilt.edu (C.L.A.); justin.balko{at}vanderbilt.edu (J.M.B.)